US Patent Issued to University of Southampton on June 10 for "Cancer and B-cell related disease therapy" (British Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,754, issued on June 10, was assigned to University of Southampton (Southampton, Great Britain).

"Cancer and B-cell related disease therapy" was invented by Martin John Glennie (Southampton, Great Britain), Aymen Al-Shamkhani (Southampton, Great Britain), Mark Steven Cragg (Southampton, Great Britain) and Sean Hua Lim (Southampton, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to a method of treatment or prevention of B-cell related disease in a subject comprising the administration of a binding molecule capable of binding to a B-cell and promoting killing of the B-cell; and an immunostimulatory agent arranged to...